Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hypersensitivity Reaction

  Free Subscription


Articles published in J Invest Dermatol

Retrieve available abstracts of 51 articles:
HTML format
Text format



Single Articles


    May 2017
  1. NIJSTEN T
    Atopic Dermatitis and Comorbidities: Added Value of Comprehensive Dermatoepidemiology.
    J Invest Dermatol. 2017;137:1009-1011.
    PubMed     Text format     Abstract available


    March 2017
  2. NARLA S, Hsu DY, Thyssen JP, Silverberg JI, et al
    Inpatient financial burden of atopic dermatitis in the United States.
    J Invest Dermatol. 2017 Mar 1. pii: S0022-202X(17)31160.
    PubMed     Text format     Abstract available


  3. OCHI H, Takai T, Shimura S, Maruyama N, et al
    Skin Treatment with Detergent Promotes Protease Allergen-Dependent Epicutaneous Sensitization in a Manner Different from Tape Stripping in Mice.
    J Invest Dermatol. 2017 Mar 1. pii: S0022-202X(17)31155.
    PubMed     Text format    


    February 2017
  4. WILKES SR, Nankervis H, Tavernier E, Maruani A, et al
    More atopic dermatitis trials using standard treatments as active comparators please.
    J Invest Dermatol. 2017 Feb 26. pii: S0022-202X(17)31145.
    PubMed     Text format    


  5. LANGAN SM, Abuabara K, Henrickson SE, Hoffstad O, et al
    Increased risk of cutaneous and systemic infections in atopic dermatitis - A cohort study.
    J Invest Dermatol. 2017 Feb 12. pii: S0022-202X(17)30175.
    PubMed     Text format    


  6. BLOMBERG M, Rifas-Shiman SL, Camargo CA Jr, Gold DR, et al
    Low maternal prenatal 25-hydroxy vitamin D blood levels are associated with childhood atopic dermatitis.
    J Invest Dermatol. 2017 Feb 12. pii: S0022-202X(17)30174.
    PubMed     Text format    


  7. SIEGFRIED EC, Jaworski JC, Eichenfield LF, Hebert AA, et al
    Optimizing Clinical Trials for Atopic Dermatitis in Children.
    J Invest Dermatol. 2017 Feb 9. pii: S0022-202X(17)30167.
    PubMed     Text format    


    January 2017
  8. BANDO K, Tanaka Y, Kuroishi T, Sasaki K, et al
    Mouse Model of Hydroquinone Hypersensitivity via Innate and Acquired Immunity, and its Promotion by Combined Reagents.
    J Invest Dermatol. 2017 Jan 17. pii: S0022-202X(17)30015.
    PubMed     Text format     Abstract available


    December 2016
  9. STANDL M, Tesch F, Baurecht H, Rodriguez E, et al
    Association of atopic dermatitis with cardiovascular risk factors and diseases.
    J Invest Dermatol. 2016 Dec 20. pii: S0022-202X(16)32791.
    PubMed     Text format     Abstract available


  10. SU SC, Mockenhaupt M, Wolkenstein P, Dunant A, et al
    Interleukin-15 is associated with severity and mortality in Stevens-Johnson syndrome/toxic epidermal necrolysis.
    J Invest Dermatol. 2016 Dec 20. pii: S0022-202X(16)32797.
    PubMed     Text format     Abstract available


  11. NOUSBECK J, Irvine AD
    Atopic Dermatitis According to GARP: New Mechanistic Insights in Disease Pathogenesis.
    J Invest Dermatol. 2016;136:2340-2341.
    PubMed     Text format     Abstract available


    November 2016
  12. KIM D, Lee NR, Park SY, Jun M, et al
    As in atopic dermatitis, non-lesional skin in allergic contact dermatitis displays abnormalities in barrier function and ceramide content.
    J Invest Dermatol. 2016 Nov 5. pii: S0022-202X(16)32623.
    PubMed     Text format    


  13. UNGAR B, Garcet S, Gonzalez J, Dhingra N, et al
    An integrated model of atopic dermatitis biomarkers highlights the systemic nature of the disease.
    J Invest Dermatol. 2016 Nov 4. pii: S0022-202X(16)32620.
    PubMed     Text format     Abstract available


    October 2016
  14. BRUNNER PM, Silverberg JI, Guttman-Yassky E, Paller AS, et al
    Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder.
    J Invest Dermatol. 2016 Oct 20. pii: S0022-202X(16)32366.
    PubMed     Text format     Abstract available


  15. IGAWA S, Kishibe M, Minami-Hori M, Honma M, et al
    Incomplete KLK7 secretion and upregulated LEKTI expression underlie hyperkeratotic stratum corneum in atopic dermatitis.
    J Invest Dermatol. 2016 Oct 18. pii: S0022-202X(16)32509.
    PubMed     Text format     Abstract available


  16. ADAM C, Wohlfarth J, Haussmann M, Sennefelder H, et al
    Allergy-inducing chromium compounds trigger potent innate immune stimulation via ROS-dependent inflammasome activation.
    J Invest Dermatol. 2016 Oct 14. pii: S0022-202X(16)32494.
    PubMed     Text format     Abstract available


  17. LIU Y, Wang Z, De La Torre R, Barling A, et al
    Trim32 deficiency enhances Th2 immunity and predisposes to features of atopic dermatitis.
    J Invest Dermatol. 2016 Oct 5. pii: S0022-202X(16)32467.
    PubMed     Text format     Abstract available


    September 2016
  18. DOI T, Mizukawa Y, Shimoda Y, Yamazaki Y, et al
    Importance of Water Content of the Stratum Corneum in Mouse Models for Contact Hypersensitivity.
    J Invest Dermatol. 2016 Sep 17. pii: S0022-202X(16)32450.
    PubMed     Text format     Abstract available


  19. MAHNKE K, Useliene J, Ring S, Kage P, et al
    Down-regulation of CD62L shedding in T cells by CD39+ regulatory T cells leads to defective sensitization in contact hypersensitivity reactions.
    J Invest Dermatol. 2016 Sep 10. pii: S0022-202X(16)32367.
    PubMed     Text format     Abstract available


  20. DRUCKER AM, Wang AR, Li WQ, Sevetson E, et al
    The Burden of Atopic Dermatitis: Summary of a Report for the National Eczema Association.
    J Invest Dermatol. 2016 Sep 8. pii: S0022-202X(16)32120.
    PubMed     Text format     Abstract available


    July 2016
  21. MANZ J, Rodriguez E, ElSharawy A, Oesau EM, et al
    Targeted resequencing and functional testing identifies low-frequency missense variants in the gene encoding GARP as significant contributors to atopic dermatitis risk.
    J Invest Dermatol. 2016 Jul 20. pii: S0022-202X(16)32116.
    PubMed     Text format     Abstract available


  22. NAKATSUJI T, Chen TH, Two AM, Chun KA, et al
    Staphylococcus aureus exploits epidermal barrier defects in atopic dermatitis to trigger cytokine expression.
    J Invest Dermatol. 2016 Jul 2. pii: S0022-202X(16)32091.
    PubMed     Text format     Abstract available


    June 2016
  23. OLIVRY T, Mayhew D, Paps JS, Linder KE, et al
    Early Activation of Th2/Th22 Inflammatory and Pruritogenic Pathways in Acute Canine Atopic Dermatitis Skin Lesions.
    J Invest Dermatol. 2016 Jun 21. pii: S0022-202X(16)31360.
    PubMed     Text format     Abstract available


  24. SANTORO D, Rodrigues Hoffmann A
    Canine and Human Atopic Dermatitis: Two Faces of the Same Host-Microbe Interaction.
    J Invest Dermatol. 2016;136:1087-9.
    PubMed     Text format     Abstract available


    May 2016
  25. SILVERBERG JI, Song J, Pinto D, Yu SH, et al
    Atopic dermatitis is associated with less physical activity in US adults.
    J Invest Dermatol. 2016 May 14. pii: S0022-202X(16)31146.
    PubMed     Text format     Abstract available


  26. WANG X, Hu C, Wu X, Wang S, et al
    Roseotoxin B Improves Allergic Contact Dermatitis through a Unique Anti-inflammatory Mechanism Involving Excessive Activation of Autophagy in Activated T-Lymphocytes.
    J Invest Dermatol. 2016 May 4. pii: S0022-202X(16)31138.
    PubMed     Text format     Abstract available


    April 2016
  27. WINGET J, Finlay D, Mills KJ, Huggins T, et al
    Quantitative proteomic analysis of Stratum Corneum dysfunction in adult chronic Atopic Dermatitis.
    J Invest Dermatol. 2016 Apr 14. pii: S0022-202X(16)31034.
    PubMed     Text format    


    March 2016
  28. BALATO A, Mattii M, Caiazzo G, Raimondo A, et al
    IL-36gamma is involved in psoriasis and allergic contact dermatitis.
    J Invest Dermatol. 2016 Mar 25. pii: S0022-202X(16)30983.
    PubMed     Text format    


  29. SEHRA S, Serezani AP, Ocana JA, Travers JB, et al
    Mast Cells Regulate Epidermal Barrier Function and the Development of Allergic Skin Inflammation.
    J Invest Dermatol. 2016 Mar 25. pii: S0022-202X(16)30980.
    PubMed     Text format     Abstract available


  30. SHIMURA S, Takai T, Iida H, Maruyama N, et al
    Epicutaneous Allergic Sensitization by Cooperation between Allergen Protease Activity and Mechanical Skin Barrier Damage in Mice.
    J Invest Dermatol. 2016 Mar 14. pii: S0022-202X(16)30873.
    PubMed     Text format     Abstract available


  31. MEGURO K, Nakagomi D, Suzuki K, Hosokawa J, et al
    SOCS3 Expressed in M2 Macrophages Attenuates Contact Hypersensitivity by Suppressing MMP-12 Production.
    J Invest Dermatol. 2016;136:649-657.
    PubMed     Text format     Abstract available


  32. HONZKE S, Wallmeyer L, Ostrowski A, Radbruch M, et al
    Influence of Th2 Cytokines on the Cornified Envelope, Tight Junction Proteins, and ?-Defensins in Filaggrin-Deficient Skin Equivalents.
    J Invest Dermatol. 2016;136:631-639.
    PubMed     Text format     Abstract available


  33. STRID J, McLean WH, Irvine AD
    Too Much, Too Little or Just Enough: A Goldilocks Effect for IL-13 and Skin Barrier Regulation?
    J Invest Dermatol. 2016;136:561-4.
    PubMed     Text format     Abstract available


    February 2016
  34. BRADLEY CW, Morris DO, Rankin SC, Cain CL, et al
    Longitudinal evaluation of the skin microbiome and association with microenvironment and treatment in canine atopic dermatitis.
    J Invest Dermatol. 2016 Feb 5. pii: S0022-202X(16)00455.
    PubMed     Text format     Abstract available


  35. YANG G, Oh JW, Lee HE, Lee BH, et al
    Topical Application of Dieckol Ameliorates Atopic Dermatitis in NC/Nga Mice by Suppressing Thymic Stromal Lymphopoietin Production.
    J Invest Dermatol. 2016 Feb 5. pii: S0022-202X(16)00454.
    PubMed     Text format    


  36. DIEPGEN TL, Naldi L, Bruze M, Cazzaniga S, et al
    Prevalence of Contact Allergy to p-Phenylenediamine in the European General Population.
    J Invest Dermatol. 2016;136:409-15.
    PubMed     Text format     Abstract available


  37. SAKAI T, Hatano Y, Matsuda-Hirose H, Zhang W, et al
    Combined Benefits of a PAR2 Inhibitor and Stratum Corneum Acidification for Murine Atopic Dermatitis.
    J Invest Dermatol. 2016;136:538-541.
    PubMed     Text format    


  38. LI JL, Lim CH, Tay FW, Goh CC, et al
    Neutrophils Self-Regulate Immune Complex-Mediated Cutaneous Inflammation through CXCL2.
    J Invest Dermatol. 2016;136:416-24.
    PubMed     Text format     Abstract available


    January 2016
  39. TORIGOE K, Tominaga M, Ko KC, Takahashi N, et al
    Intrathecal minocycline suppresses itch-related behavior and improves dermatitis in a mouse model of atopic dermatitis.
    J Invest Dermatol. 2016 Jan 28. pii: S0022-202X(16)00354.
    PubMed     Text format    


  40. NOH S, Jin S, Park CO, Lee YS, et al
    Elevated Galectin-10 Expression of IL-22-Producing T Cells in Patients with Atopic Dermatitis.
    J Invest Dermatol. 2016;136:328-31.
    PubMed     Text format    


  41. CARRETERO M, Guerrero-Aspizua S, Illera N, Galvez V, et al
    Differential Features between Chronic Skin Inflammatory Diseases Revealed in Skin-Humanized Psoriasis and Atopic Dermatitis Mouse Models.
    J Invest Dermatol. 2016;136:136-45.
    PubMed     Text format     Abstract available


  42. JANG H, Matsuda A, Jung K, Karasawa K, et al
    Skin pH Is the Master Switch of Kallikrein 5-Mediated Skin Barrier Destruction in a Murine Atopic Dermatitis Model.
    J Invest Dermatol. 2016;136:127-35.
    PubMed     Text format     Abstract available


  43. LEE HG, Cho NC, Jeong AJ, Li YC, et al
    Immunomodulatory Activities of the Benzoxathiole Derivative BOT-4-One Ameliorate Pathogenic Skin Inflammation in Mice.
    J Invest Dermatol. 2016;136:107-16.
    PubMed     Text format     Abstract available


    December 2015
  44. SHALOM G, Linder D, Comaneshter D, Nathan A, et al
    Healthcare Services Utilization and Drug Use in Patients with Chronic Urticaria.
    J Invest Dermatol. 2015;135:3187-9.
    PubMed     Text format    


    November 2015
  45. MURRAY C, Ahrens K, Devalaraja M, Dymond M, et al
    Use of a Canine Model of Atopic Dermatitis to Investigate the Efficacy of a CCR4 Antagonist in Allergen-Induced Skin Inflammation in a Randomized Study.
    J Invest Dermatol. 2015 Nov 18. pii: S0022-202X(15)00067.
    PubMed     Text format     Abstract available


    October 2015
  46. BRAUWEILER AM, Goleva E, Hall CF, Leung DY, et al
    Th2 Cytokines Suppress Lipoteichoic Acid-Induced Matrix Metalloproteinase Expression and Keratinocyte Migration in Response to Wounding.
    J Invest Dermatol. 2015;135:2550-3.
    PubMed     Text format    


    August 2015
  47. HAARMANN-STEMMANN T, Esser C, Krutmann J
    The Janus-Faced Role of Aryl Hydrocarbon Receptor Signaling in the Skin: Consequences for Prevention and Treatment of Skin Disorders.
    J Invest Dermatol. 2015 Aug 13. doi: 10.1038/jid.2015.
    PubMed     Text format     Abstract available


  48. PANAYOTOVA-DIMITROVA D, Feoktistova M, Leverkus M
    RIPping the Skin Apart: Necroptosis Signaling in Toxic Epidermal Necrolysis.
    J Invest Dermatol. 2015;135:1940-3.
    PubMed     Text format     Abstract available


    May 2015
  49. CHUNG WH, Pan RY, Chu MT, Chin SW, et al
    Oxypurinol-Specific T cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions.
    J Invest Dermatol. 2015 May 6. doi: 10.1038/jid.2015.
    PubMed     Text format     Abstract available


    April 2015
  50. SAVINKO T, Morrison V, Uotila L, Wolff H, et al
    Functional Beta2-Integrins Restrict Skin Inflammation In Vivo.
    J Invest Dermatol. 2015 Apr 28. doi: 10.1038/jid.2015.
    PubMed     Text format     Abstract available


    March 2015
  51. KYUNG KIM S, Kim WJ, Yoon JH, Ji JH, et al
    Upregulated RIP3 Expression Potentiates MLKL Phosphorylation-Mediated Programmed Necrosis in Toxic Epidermal Necrolysis.
    J Invest Dermatol. 2015 Mar 6. doi: 10.1038/jid.2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: